Popular obesity drug may help treat sleep apnoea
A popular weight-loss drug may help people who struggle with a serious sleep disorder, according to a new study. Tirzepatide, the medication in the weight-loss drug Zepbound and the diabetes treatment Mounjaro, appeared to reduce the severity of sleep apnoea, according to a new study. The findings were published in the New England Journal of Medicine last week, and included 469 people with obesity and obstructive sleep apnoea (OSA). OSA is a disorder where people stop breathing while they are asleep because the tissue in the throat relaxes and collapses during sleep, fully or partially blockin...